1887

Abstract

Forty-six overlapping peptides (20-mers) representing the amino acid sequence of the external envelope glycoprotein of simian immunodeficiency virus (SIV; 32H isolate) were used to investigate linear antigenic sites recognized by antibodies in sera from SIV-infected rhesus macaques and in animals vaccinated with formalin-inactivated SIV. The reactivity to a discontinuous antigenic site as defined by a neutralizing monoclonal antibody was measured by competition assay. The majority of infected macaques recognized three linear antigenic determinants within the V1, V3 and C5 regions of the external glycoprotein. Animals infected with virus derived from the molecular clone SIV 32H (pJ5) showed broader reactivity to peptides with half of these animals having antibodies to the V2 region in addition to the V1, V3 and C5 regions. The majority of animals produced antibodies in response to the discontinuous epitope although these responses were weaker in animals infected with molecularly cloned virus. Seven of eight animals given vaccine in syntex adjuvant formulation (saf-1) produced antibodies in response to the discontinuous epitope and all reacted with peptides from the V1, V2 and V3 regions but only half recognized the C5 region. Animals receiving vaccine in alum adjuvant generally showed weaker responses to the discontinuous and linear determinants than those receiving saf-1 adjuvanted vaccine.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-74-6-1033
1993-06-01
2022-08-16
Loading full text...

Full text loading...

/deliver/fulltext/jgv/74/6/JV0740061033.html?itemId=/content/journal/jgv/10.1099/0022-1317-74-6-1033&mimeType=html&fmt=ahah

References

  1. Almond N., Jenkins A., Slade A., Heath A., Cranage M. P., Kitchin P. 1992; Population sequence analysis of a simian immunodeficiency virus (32H reisolate of SIVmac251): a virus stock used for international vaccine studies. AIDS Research and Human Retroviruses 8:77–88
    [Google Scholar]
  2. Baskerville A., Ramsay A., Cranage M. P., Cook N., Cook R. W., Dennis M. J., Greenaway P. J., Kitchin P. A., Stott E. J. 1990; Histopathological changes in simian immunodeficiency virus infection. Journal of Pathology 162:67–75
    [Google Scholar]
  3. Benichou S., Legrand R., Nakagawa N., Faure T., Traincard F., Vogt G., Dormont D., Tiollais P., Kieny M.-P., Madaule P. 1992; Identification of a neutralizing domain in the external envelope glycoprotein of simian immunodeficiency virus. AIDS Research and Human Retroviruses 8:1165–1170
    [Google Scholar]
  4. Berman P. W., Gregory T. J., Riddle L., Nakamura G. R., Champe M. A., Porter J. P., Wurm F. M., Hershbery R. D., Cobb E. K., Eichberg J. W. 1990; Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gpl20 but not gpl60. Nature, London 345:622–625
    [Google Scholar]
  5. Burns D. P. W., Desrosiers R. C. 1991; Selection of genetic variants of simian immunodeficiency virus in persistently infected rhesus monkeys. Journal of Virology 65:1843–1854
    [Google Scholar]
  6. Chakrabarti L., Guyader M., Alizon M., Daniel M. D., Desrosiers R. C., Tiollais P., Sonigo P. 1987; Sequence of simian immunodeficiency virus from macaque and its relationship to other human and simian retroviruses. Nature, London 328:543–547
    [Google Scholar]
  7. Cranage M. P., Cook N., Johnstone P., Greenaway P. J., Kitchin P. A., Stott E. J., Almond N., Baskerville A. 1990; SIV infection of macaques: in vivo titration of infectivity and development of an experimental vaccine. In Animal Models of AIDS pp. 103–113 Edited by Schellekens H., Horzinek M. C. Amsterdam: Elsevier;
    [Google Scholar]
  8. Cranage M. P., Stott J., Mills K., Ashworth T., Taffs F., Farrar G., Chan L., Dennis M., Putkonen P., Biberfeld G., Murphy-Corb M., Page M., Baskerville A., Kitchin P., Greenaway P. 1992; Vaccine studies with the 32H reisolate of SIVmac261: an overview. AIDS Research and Human Retroviruses 8:1479–1481
    [Google Scholar]
  9. Cranage M. P., Polyanskaya N., McBride B. W., Cook N., Ashworth L. A. E., Dennis M., Baskerville A., Greenaway P., Corcoran T., Kitchin P., Rose R., Murphey-Corb M., Desrosiers R. C., Stott E. J., Farrar G. H. 1993; Studies on the specificity of the vaccine effect elicited by inactivated simian immunodeficiency virus. AIDS Research and Human Retroviruses 9:13–22
    [Google Scholar]
  10. Desrosiers R. C., Letvin N. 1987; Animal models for acquired immunodeficiency syndrome. Reviews of Infectious Diseases 9:438–146
    [Google Scholar]
  11. Emini E. A., Schleif W. A., Nunberg J. H., Conley A. J., Eda J., Tokiyoshi S., Putney S. D., Matsushita S., Cobb K. E., Jett C. M. 1992; Prevention of HIV-1 infection in chimpanzees by gpl20 V3 domain-specific monoclonal antibody. Nature, London 355:728–730
    [Google Scholar]
  12. Fenouillet E., Gluckman J. C. 1992; Immunological analysis of human immunodeficiency virus type 1 envelope glycoprotein proteolytic cleavage. Virology 187:825–828
    [Google Scholar]
  13. Fung M. S. C., Sun C. R. Y., Gordon W. L., Liou R. S., Chang T. W., Sun W. N. C., Daar E. S., Ho D. D. 1992; Identification and characterization of a neutralization site within the second variable region of human immunodeficiency virus type 1 gpl20. Journal of Virology 66:848–856
    [Google Scholar]
  14. Goudsmit J., Boucher C. A. B., Meloen R. H., Epstein L. G., Smit L., Van Der Hoek L., Barker M. 1988; Human antibody response to a strain-specific HIV-1 gpl20 epitope associated with cell fusion inhibition. AIDS 2:157–164
    [Google Scholar]
  15. Goudsmit J., Barker M., de Wolf F., Langedijk H., Meloen R., Thiriart C., Bruck C., McEntee M., Nauayan O., Nara P., Heeney J. 1992; Characterization of the serological responses in experimentally infected rhesus monkeys by competition with neutralizing and non-neutralizing mouse monoclonal antibodies and peptide reactivity. In Vaccines 92 pp. 165–170 Edited by Brown F., Chanock R. M., Ginsberg H. S., Lerner R. A. New York: Cold Spring Harbor Laboratory;
    [Google Scholar]
  16. Haigwood N. L., Nara P. L., Brooks E., Van Nest G. A., Ott G., Higgins K. W., Dunlop N., Scandella C. J., Eichberg J. W., Steimer K. S. 1992; Native but not denatured recombinant human immunodeficiency virus type 1 gpl20 generates broad-spectrum neutralizing antibodies in baboons. Journal of Virology 66:172–182
    [Google Scholar]
  17. Helseth E., Olshevsky U., Furman C., Sodroski J. 1991; Human immunodeficiency virus type 1 gpl20 envelope glycoprotein regions important for association with the gp41 transmembrane glycoprotein. Journal of Virology 65:2119–2123
    [Google Scholar]
  18. Hounsell E., Renouf F. V., Liney D., Dalgleish A. G., Habeshaw J. 1992; A proposed molecular model for the carboxy terminus of HIV-1 gpl20 showing structural features consistant with the presence of a T cell alloepitope. Molecular Aspects of Medicine 12:283–296
    [Google Scholar]
  19. Hu S.-L., Abrams K., Barber G. N., Moran P., Zarling J. M., Langlois A. J., Kuller L., Morton W. R., Benveniste R. E. 1992; Protection of macaques against SIV infection by subunit vaccines of SIV envelope glycoprotein gpl60. Science 255:456–459
    [Google Scholar]
  20. Javaherian K., Langlois A. J., Schmidt S., Kaufmann M., Cates N., Langedijk J. P. M., Meloen R. H., Desrosiers R. C., Burns D. P. W., Bolognesi D. P., LaRosa G. J., Putney S. D. 1992; The principal neutralization determinant of simian immunodeficieny virus differs from that of human immunodeficiency virus type 1. Proceedings of the National Academy of Sciences, U.S.A. 89:1418–1422
    [Google Scholar]
  21. Kent K. A., Gritz L., Stallard G., Cranage M. P., Collignon C., Thiriart C., Corcoran T., Sil vera P., Stott E. J. 1991; Production and characterisation of monoclonal antibodies to simian immunodeficiency virus envelope glycoproteins. AIDS 5:829–836
    [Google Scholar]
  22. Kent K. A., Rud E., Corcoran T., Powell C., Thiriart C., Collignon C., Stott E. J. 1992; Identification of two neutralizing and 8 non-neutralizing epitopes on simian immunodeficiency virus envelope using monoclonal antibodies. AIDS Research and Human Retroviruses 8:1147–1151
    [Google Scholar]
  23. Kitchin P. A., Cranage M. P., Almond N., Barnard A., Baskerville A., Corcoran T., Fromholc C., Greenaway P., Grief C., Jenkins A., Kent K., Ling C., Mahon B., Mills K., Page M., Sil vera P., Szotyori Z., Taffs F., Stott E. J. 1990; Titration of SIVmac251 (32H isolate) in cynomologus macaques for use as a challenge in vaccination studies. In Animal Models in AIDS pp. 115–129 Edited by Schellekens H., Horzinek M. C. Amsterdam: Elsevier;
    [Google Scholar]
  24. Le Grand R., Vogt G., Vaslin B., Roques P., Theodoro F., Aubertin A. M., Dormont D. 1992; Specific and non-specific immunity and protection of macaques against SIV infection. Vaccine 10:873–879
    [Google Scholar]
  25. MannerviK M., Putkonen P., Ruden U., Kent K. A., Norrby E., Wahren B., Broliden P. A. 1992; Identification of B-cell antigenic sites on HIV-2 gpl25. Journal of Acquired Immune Deficiency Syndromes 5:177–187
    [Google Scholar]
  26. Norrby E., Putkonen P., Bottiger B., Utter G., Biberfeld G. 1991; Comparison of linear antigenic sites in the envelope proteins of human immunodeficiency virus (HIV) type 2 and type 1. AIDS Research and Human Retroviruses 7:279–285
    [Google Scholar]
  27. Palker T. J., Matthews T. J., Clark M. E., Cianciolo G. J., Randall R. R., Langlois A. J., White G. C., Sapai B., Snyder-man R., Bolognesi D. P., Haynes B. F. 1987; A conserved region at the COOH terminus of human immunodeficiency virus gpl20 envelope protein contains an immunodominant epitope. Proceedings of the National Academy of Sciences, U.S.A. 84:2479–2483
    [Google Scholar]
  28. Profy A. T., Salinas P. A., Eckler L. I., Dunlop N. M., Nara P. L., Putney S. D. 1990; Epitopes recognised by the neutralizing antibodies of an HIV-1 infected individual. Journal of Immunology 144:4641–1647
    [Google Scholar]
  29. Putkonen P., Thorstensson R., Ghavamzadeh L. 1991; Prevention of HIV-2 and SIVsm infection by passive immunisation in cynomolgus monkeys. Nature, London 352:436–438
    [Google Scholar]
  30. Rud E. W., Yon J. R., Larder B. A., Clarke B. D., Cook N., Cranage M. P. 1992; Infectious molecular clones of SIVmac32H: nef deletion controls ability to reisolate virus from rhesus macaques. In Vaccines 92 pp. 229–235 Edited by Brown F., Chanock R. M., Ginsberg H. S., Lerner R. A. New York: Cold Spring Harbor Laboratory;
    [Google Scholar]
  31. Rusche J. R., Javaherian K., McDanal C., Petro J., Lynn D. L., Grimaila R., Langlois A., Gallo R. C., Arthur L. O., Fischinger P. J., Bolognesi D. P., Putney S. D., Matthews T. J. 1988; Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gpl20. Proceedings of the National Academy of Sciences, U.S.A. 85:3198–3202
    [Google Scholar]
  32. Shafferman A., Jahrling P. B., Benveniste R. E., Lewis M. G., Phipps T. J., Eden-McCutchan F., Sadoff J., Eddy G. A., Burke D. S. 1991; Protection of macaques with a simian immunodeficiency virus envelope peptide vaccine based on conserved human immunodeficiency virus type 1 sequences. Proceedings of the National Academy of Sciences, U.S.A. 88:7126–7130
    [Google Scholar]
  33. Spear G. T., Sullivan B. L., Landay A. L., Lint T. F. 1990; Neutralization of human immunodeficiency virus type 1 by complement occurs by viral lysis. Journal of Virology 64:5869–5873
    [Google Scholar]
  34. Stephens D. M., Eichberg J. W., Haigwood N. L., Steimer K. S., Davis D., Lachmann P. J. 1992; Antibodies are produced to the variable regions of the external envelope glycoprotein of human immunodeficiency virus type 1 in chimpanzees infected with the virus and baboons immunized with a candidate recombinant vaccine. Journal of General Virology 73:1099–1106
    [Google Scholar]
  35. Stott E. J., Kitchin P. A., Page M., Flanagan B., Taffs L. F., Chan W. L., Mills K. H. G., Silvera P., Rogers A. 1991 Nature, London correspondence 353–393
    [Google Scholar]
  36. Sun N.-C., Ho D. D., Sun C. R. Y., Liou R.-S., Gorden W., Fung M. S. C., Li X.-L., Ting R. C., Lee T.-H., Chang N. T., Chang T.-W. 1989; Generation and characterization of monoclonal antibodies to the putative CD-4 binding domain of human immunodeficiency virus type 1 gpl20. Journal of Virology 63:3579–3585
    [Google Scholar]
  37. Tyler D. S., Lyerly H. K., Weinhold K. J. 1989; Anti-HIV-1 ADCC. AIDS Research and Human Retroviruses 5:557–563
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-74-6-1033
Loading
/content/journal/jgv/10.1099/0022-1317-74-6-1033
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error